Loading...
ROCO
1781
Market cap17mUSD
Jul 09, Last price  
11.95TWD
1D
-0.42%
1Q
0.42%
Jan 2017
-38.72%
IPO
-55.66%
Name

Health&Life Co Ltd

Chart & Performance

D1W1MN
ROCO:1781 chart
P/E
—
P/S
1.42
EPS
—
Div Yield, %
—
Shrs. gr., 5y
-0.03%
Rev. gr., 5y
-12.46%
Revenues
398m
-43.65%
1,067,608,0001,176,827,0001,096,613,000975,460,0001,262,183,000795,632,0001,339,841,0001,344,645,000618,528,000684,604,000631,889,000534,459,000617,598,000421,164,000774,155,000811,879,000797,542,000601,171,000706,388,000398,046,000
Net income
-62m
L
-88,626,00017,600,000-54,528,000-41,359,00080,501,000-30,055,00081,047,00027,296,000-52,740,000-62,029,000-75,432,000-68,046,000-38,458,000-76,439,000205,980,000-62,341,000-17,548,000-33,229,00024,239,000-61,666,000
CFO
3m
-90.45%
-46,292,00059,166,00063,197,000-20,367,00027,892,000117,527,000-140,897,00040,892,000-55,912,00015,162,000-84,438,0009,606,000-34,359,000-131,150,000-80,695,00084,910,00033,353,0003,184,000
Dividend
Jul 25, 20140.5 TWD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Health & Life Co., Ltd. is a global provider of medical devices. Established in 1996 and headquartered in New Taipei City, Taiwan, the company specializes in developing and distributing solutions for critical health sectors, including cardiovascular health, in-vitro diagnostics, and respiratory care. Its diverse product line encompasses advanced vibrating mesh nebulizers, blood pressure monitoring systems, infrared thermometers, and various hearing aid technologies.
URL
https://www.healthandlife.com.tw/
IPO date
Jan 09, 2004
Employees
Domiciled in
TW
Incorporated in
TW

Valuation

Title
TWD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT